Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 104
of 6Next
1:

Bench-to-bedside review: sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter?

Gao H, Evans TW, Finney SJ.

Crit Care. 2008;12(3):213. Epub 2008 May 6. Review.

PMID: 18466647 [PubMed - indexed for MEDLINE]

2:

Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?

Opal SM, Cohen J.

Crit Care Med. 1999 Aug;27(8):1608-16. Review.

PMID: 10470773 [PubMed - indexed for MEDLINE]

3:

Emerging therapies for sepsis and septic shock.

Oh HM.

Ann Acad Med Singapore. 1998 Sep;27(5):738-43. Review.

PMID: 9919353 [PubMed - indexed for MEDLINE]

4:

Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults.

Sutherland AM, Walley KR, Russell JA.

Crit Care Med. 2005 Mar;33(3):638-44.

PMID: 15753758 [PubMed - indexed for MEDLINE]

5:

Severe sepsis and Toll-like receptors.

Gao H, Leaver SK, Burke-Gaffney A, Finney SJ.

Semin Immunopathol. 2008 Feb;30(1):29-40. Epub 2007 Dec 11. Review.

PMID: 18071706 [PubMed - indexed for MEDLINE]

6:

Current prospects for the treatment of clinical sepsis.

Suffredini AF.

Crit Care Med. 1994 Jul;22(7):S12-8. Review.

PMID: 8026188 [PubMed - indexed for MEDLINE]

7:

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM; Surviving Sepsis Campaign Management Guidelines Committee.

Crit Care Med. 2004 Mar;32(3):858-73. Review. Erratum in: Crit Care Med. 2004 Jun;32(6):1448. Correction of dosage error in text. Crit Care Med. 2004 Oct;32(10):2169-70.

PMID: 15090974 [PubMed - indexed for MEDLINE]

8:

Lack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsis.

Macias WL, Nelson DR, Williams M, Garg R, Janes J, Sashegyi A.

Crit Care. 2005;9(6):R607-22. Epub 2005 Sep 22. Review.

PMID: 16280057 [PubMed - indexed for MEDLINE]

9:

Sepsis and septic shock.

Zanetti G, Baumgartner JD, Glauser MP.

Schweiz Med Wochenschr. 1997 Mar 22;127(12):489-99. Review.

PMID: 9106949 [PubMed - indexed for MEDLINE]

10:

[Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis.]

Perego AF, Morabito S, Graziani G, Casella GP, Parodi O.

G Ital Nefrol. 2006 May-Jun;23 Suppl 36:S94-102. Italian. Erratum in: G Ital Nefrol. 2007 Nov-Dec;24(6):628-9.

PMID: 17068736 [PubMed - indexed for MEDLINE]

11:

Sepsis since the discovery of Toll-like receptors: disease concepts and therapeutic opportunities.

Leaver SK, Finney SJ, Burke-Gaffney A, Evans TW.

Crit Care Med. 2007 May;35(5):1404-10. Review.

PMID: 17414083 [PubMed - indexed for MEDLINE]

12:

Gram-positive sepsis. Mechanisms and differences from gram-negative sepsis.

Sriskandan S, Cohen J.

Infect Dis Clin North Am. 1999 Jun;13(2):397-412. Review.

PMID: 10340174 [PubMed - indexed for MEDLINE]

13:

Endotoxin as a drug target.

Opal SM, Glück T.

Crit Care Med. 2003 Jan;31(1 Suppl):S57-64. Review.

PMID: 12544978 [PubMed - indexed for MEDLINE]

14:

Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans.

Woehrle T, Du W, Goetz A, Hsu HY, Joos TO, Weiss M, Bauer U, Brueckner UB, Marion Schneider E.

Cytokine. 2008 Mar;41(3):322-9. Epub 2008 Jan 30.

PMID: 18249133 [PubMed - indexed for MEDLINE]

15:

Cytokine modulation in sepsis and septic shock.

Zanotti S, Kumar A, Kumar A.

Expert Opin Investig Drugs. 2002 Aug;11(8):1061-75. Review.

PMID: 12150702 [PubMed - indexed for MEDLINE]

16:

Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review.

Bochud PY, Bonten M, Marchetti O, Calandra T.

Crit Care Med. 2004 Nov;32(11 Suppl):S495-512. Review.

PMID: 15542958 [PubMed - indexed for MEDLINE]

17:

Passive immunotherapy of gram-negative bacteremia, sepsis and septic shock.

Spapen HD, Diltoer M, Huyghens LP.

Acta Clin Belg. 1993;48(1):20-9. Review.

PMID: 7684546 [PubMed - indexed for MEDLINE]

18:

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL.

Intensive Care Med. 2008 Jan;34(1):17-60. Epub 2007 Dec 4. Erratum in: Intensive Care Med. 2008 Apr;34(4):783-5.

PMID: 18058085 [PubMed - indexed for MEDLINE]

19:

Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials.

Trzeciak S, Cinel I, Phillip Dellinger R, Shapiro NI, Arnold RC, Parrillo JE, Hollenberg SM; Microcirculatory Alterations in Resuscitation and Shock (MARS) Investigators.

Acad Emerg Med. 2008 May;15(5):399-413. Review.

PMID: 18439194 [PubMed - indexed for MEDLINE]

20:

Current guidelines for the treatment of severe pneumonia and sepsis.

Bodmann KF.

Chemotherapy. 2005 Aug;51(5):227-33. Review.

PMID: 16103664 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 104
of 6Next